Skip to content
Home/Companies/Biotech/Anyolabs

Anyolabs

Biotech·Sweden·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Anyolabs?

Anyolabs is a Swedish Biotech company, currently owned by CVX Ventures since 2024.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
CVX Ventures
Investor
CVX Ventures
CVX Ventures · 2016 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from CVX Ventures

Other portfolio companies in the same fund.

Grow Grounds
Active
ClimateTechDenmark· 2026
Unshackled
Active
BiotechDenmark· 2025
Arctic Farming
Active
AgTechFinland· 2024
Articulate IT
Active
IT ServicesSweden· 2024
Blixt
Active
EnergySweden· 2024
Capsule
Active
HealthTechDenmark· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Anyolabs?

Anyolabs is currently owned by CVX Ventures, through CVX Ventures, since 2024.

When did CVX Ventures acquire Anyolabs?

CVX Ventures acquired Anyolabs in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue